Pub. Date : 2020 Sep
PMID : 32814829
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Receptor tyrosine kinase (RTK) inhibitors such as sunitinib have been demonstrated to target tumorigenic signaling pathways, delay tumor progression, and improve patient prognosis in metastatic renal cell carcinoma (mRCC). | Sunitinib | ret proto-oncogene | Homo sapiens |
2 | Receptor tyrosine kinase (RTK) inhibitors such as sunitinib have been demonstrated to target tumorigenic signaling pathways, delay tumor progression, and improve patient prognosis in metastatic renal cell carcinoma (mRCC). | Sunitinib | ret proto-oncogene | Homo sapiens |